Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Cannabis Science Receives FDA Industry Guidelines For Mapping Out Its Initial Drugs Offerings For FDA Submission And Testing
Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to report that the FDA has provided the Company with documentation to assist the Company to review and plan its initial applications to get its first drug into formal testing.

AlphaRx And Gaia BioPharma Report Positive Efficacy Results In A Pre-Clinical Trial Of GAI-122 Injectable Nano-emulsion For Post-operative Delirium
AlphaRx Inc. (OTCBB: ALRX) and Gaia BioPharma Limited reported positive pre-clinical results on GAI-122 injectable nanoemulsion in multiple in vitro and in vivo studies of memory impairment after prolonged anesthesia.
News of the day
Home Oxygen Patients And Family Members Visit Capitol Hill To Ask Congress To Protect Medicare Home Oxygen Therapy Benefit
Asking members of Congress to support patient-focused reform of the Medicare home oxygen therapy benefit, patients and family members with the National Emphysema/COPD Association (NECA), a national advocacy organization representing patients with chronic obstructive pulmonary disease (COPD) and other lung diseases, descended on Capitol Hill this week. Patients urged members of the U.S. House to support and pass the Medicare Home Oxygen Therapy Act of 2009 (H.R. 3220), which was recently introduced.
Mental Health

New Homeopathic Spray Offers Fast, Short-Term Relief From Nicotine Cravings

With rising taxes and increasing restrictions on smoking and tobacco, smokers looking for temporary relief from cravings and withdrawal symptoms during periods when they couldn"t smoke, or chose not to, were out of luck. But a new breed of short-term cessation treatment -- based on age-old homeopathic practices -- promises to help smokers manage cravings on-the-spot, when lighting up isn"t an option. NIX-IT is an oral spray that temporarily relieves nicotine cravings and the uncomfortable symptoms associated with nicotine withdrawal, including anxiety, irritability and dry mouth. Unlike long-term cessation products, NIX-IT acts fast and can be used as-needed, anytime, anywhere. "While NIX-IT can assist adults in quitting tobacco, it isn"t a hardcore stop-smoking product," says Dave Savoca, president of Smokey Mountain Chew, marketing company for NIX-IT. "It"s really targeted to adult tobacco consumers who need to manage tobacco cravings in specific situations. Because it"s easy to carry just about anywhere, NIX-IT is perfect for curbing cravings on long flights, at indoor events, during movies, at restaurants or anywhere else consumers can"t or choose not to smoke." Savoca says NIX-IT, manufactured in the USA at an FDA-regulated facility, falls under the newly-designated category of personal tobacco management, and will be available in retail stores nationwide. NIX-IT


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009